Why the study?
Does intravenous domperidone cause serious dysrhythmias in children with cancer receiving cytotoxic therapy?
Does intravenous domperidone cause serious dysrhythmias in children with cancer receiving cytotoxic therapy?
Intravenous domperidone at 1 mg/kg did not cause serious dysrhythmias in a small cohort of children with cancer.
May support cautious IV domperidone use in pediatric cancer; leaves open safety confirmation in larger prospective studies.
Domperidone is an effective antiemetic for children receiving cytotoxic therapy. There have been reports of cardiac arrest in older patients associated with domperidone. We carried out continuous ECG monitoring of 18 children receiving domperidone intravenously in a dose of 1 mg/kg body weight. No serious dysrhythmias were noted during 379 h of recording. Single premature beats, transient sinus pauses, and nodal block were occasionally associated with vomiting and were no more common than would be expected in a population of normal children.
No takes yet. Share an insight, caveat, or question.
Ratcliffe et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: